Biotech and Pharmaceuticals
CVS, UnitedHealth, Cigna sue to block FTC case over insulin prices
CVS Pharmacy logo is seen in Washington DC, United States on July 9, 2024. Jakub Porzycki | Nurphoto | Getty Images CVS Health, UnitedHealth Group and Cigna sued the Federal Trade Commission on Tuesday, claiming that the agency’s case against drug supply chain middlemen over high insulin prices in the U.S. is unconstitutional. The complaint, […]
Read More
RFK Jr. is Trump’s pick to lead HHS — here’s what he could do with that power
Independent presidential candidate Robert F. Kennedy Jr. makes an announcement on the future of his campaign in Phoenix, Arizona, U.S. August 23, 2024. Thomas Machowicz | Reuters President-elect Donald Trump has tapped Robert F. Kennedy Jr. to lead the Department of Health and Human Services – a selection that is raising fears in the public […]
Read More
Jim Cramer’s top 10 things to watch in the stock market Friday
My top 10 things to watch Friday, Nov. 15 1. President-elect Donald Trump’s decision to nominate prominent vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services has vast implications for drug companies. That’s why shares of pharma stocks, and vaccine makers in particular, sold off late Thursday when reports […]
Read More
Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS
Independent presidential candidate Robert F. Kennedy Jr. makes an announcement on the future of his campaign in Phoenix, Arizona, U.S. August 23, 2024. Thomas Machowicz | Reuters Shares of vaccine makers fell on Thursday as President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of Health and Human […]
Read More
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
The office building of biopharmaceutical company AstraZeneca is being seen in Shanghai, China, on May 23, 2024. Nurphoto | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. AstraZeneca said it is doubling down […]
Read More
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Omar Marques | Lightrocket | Getty Images Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss injection, MariTide. One analyst said the additional data suggests a new potential safety risk tied to the drug. But others said the share […]
Read More
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Aykut Karahan | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Happy Friday! Buried in the election news this week was new data from drugmakers vying to enter the booming weight […]
Read More
How Trump’s victory could change abortion rights in America
Anti-abortion demonstrators listen to President Donald Trump as he speaks at the 47th annual “March for Life” in Washington, D.C., Jan. 24, 2020. Olivier Douliery | Afp | Getty Images Voters in seven out of 10 states approved ballot measures this week to safeguard abortion rights, a hot-button issue that helped drive Americans to the […]
Read More
FDA proposes ending use of decongestant found in many cold, allergy medicines
A bottle of Vicks DayQuil cold and flu medicine containing phenylephrine is displayed for sale in a CVS Pharmacy store in Hawthorne, California, on Sept. 12, 2023. Patrick T. Fallon | AFP | Getty Images The Food and Drug Administration on Thursday proposed ending the use of a common ingredient found in many popular over-the-counter […]
Read More
Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
Moderna on Thursday posted a surprise profit for the third quarter, smashing Wall Street estimates, as its cost-cutting efforts took hold and sales of its Covid vaccine came in higher than expected. The biotech company posted a net income of $13 million, or 3 cents per share, for the third quarter. That compares with a […]
Read More